These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38192660)

  • 21. Clinicohistoradiological and surgical outcome in diffuse midline glioma.
    Kumar Suman A; Bhattacharjee S; Uppin MS; Fathima ST
    Childs Nerv Syst; 2024 Jan; 40(1):65-71. PubMed ID: 37644138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report.
    Wang Q; Niu W; Pan H
    Acta Neurochir (Wien); 2022 Aug; 164(8):2063-2066. PubMed ID: 34812950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pediatric bithalamic high grade glioma with concomitant H3K27M and EGFR mutations.
    Kara B; Danyeli AE; Öztürk M; Ertan K; Köksal Y
    Turk J Pediatr; 2022; 64(4):754-758. PubMed ID: 36082650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
    Pachocki CJ; Hol EM
    J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

  • 26. H3K27M Mutation Doesn't Mean Worse Prognosis in Old Patients.
    Hu XM; Nie XY; Xu KL; Wang Y; Tang F; Du ZG; Xiong J
    Front Oncol; 2022; 12():912166. PubMed ID: 35756637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis.
    Aftahy AK; Butenschoen VM; Hoenikl L; Liesche-Starnecker F; Wiestler B; Schmidt-Graf F; Meyer B; Gempt J
    BMC Neurol; 2023 Feb; 23(1):87. PubMed ID: 36855102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.
    Al Sharie S; Talafha M; Abu Laban D; Al Awabdeh T; Al-Mousa A; Al-Masri N; Al-Hussaini M
    Clin Neuropathol; 2022; 41(6):263-270. PubMed ID: 35770519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal cord diffuse midline glioma with postoperative acute swelling: A case report and review of literature.
    Karita H; Tsurubuchi T; Amano T; Koiso T; Sakamoto N; Ishikawa E
    Surg Neurol Int; 2023; 14():360. PubMed ID: 37941612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse midline glioma metastasis to the peritoneal cavity via ventriculo-peritoneal shunt: Case report and review of literature.
    Stephens S; Tollesson G; Robertson T; Campbell R
    J Clin Neurosci; 2019 Sep; 67():288-293. PubMed ID: 31266714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast-developing fatal diffuse leptomeningeal dissemination of a pineal germinoma in a young child: a case report and literature review.
    Chen R; Tao C; You C; Ju Y
    Br J Neurosurg; 2022 Apr; 36(2):262-269. PubMed ID: 30451003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker.
    Agarwal P; Aiyer HM
    Indian J Pathol Microbiol; 2021; 64(2):351-353. PubMed ID: 33851633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New progress in the treatment of diffuse midline glioma with H3K27M alteration.
    Yang Z; Sun L; Chen H; Sun C; Xia L
    Heliyon; 2024 Jan; 10(2):e24877. PubMed ID: 38312649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare High-Grade Glioma with a Histone H3 K27M Mutation in the Hypothalamus of an Adult Patient.
    He P; Chen W; Qiu XX; Xi YB; Guan H; Xia J
    World Neurosurg; 2019 Aug; 128():527-531. PubMed ID: 31048046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indolent presentation of a diffuse midline glioma, H3 K27-altered.
    Damodharan S; Helgager J; Puccetti D
    Childs Nerv Syst; 2023 Mar; 39(3):833-835. PubMed ID: 36094605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient.
    Cheng R; Li DP; Zhang N; Zhang JY; Zhang D; Liu TT; Yang J; Ge M
    Front Surg; 2021; 8():616334. PubMed ID: 34222313
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study.
    Wang Y; Feng LL; Ji PG; Liu JH; Guo SC; Zhai YL; Sankey EW; Wang Y; Xue YR; Wang N; Lou M; Xu M; Chao M; Gao GD; Qu Y; Gong L; Wang L
    Front Oncol; 2020; 10():602553. PubMed ID: 33659209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission of Pediatric Diffuse Intrinsic Pontine Glioma: Case Report and Review of the Literature.
    Espirito Santo V; Passos J; Nzwalo H; Nunes S; Salgado D
    J Pediatr Neurosci; 2021; 16(1):1-4. PubMed ID: 34316300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H3K27M mutant diffuse midline glioma: a case report.
    Luo Y; Zeng L; Xie XQ; Wang F; Liu YZ; Kang JB; Li XF; Wu DB; Qu BL
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2579-2584. PubMed ID: 32196609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
    Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J
    Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.